-+ 0.00%
-+ 0.00%
-+ 0.00%

Osaka Organic Chemical Industry (TSE:4187) Stock Faces One Off Boosted Margin Narrative Test

Simply Wall St·07/11/2026 19:25:26
语音播报

Osaka Organic Chemical Industry (TSE:4187) has reported Q2 2026 revenue of ¥10.96b and basic EPS of ¥88.54, with trailing twelve month revenue of ¥38.90b and EPS of ¥385.42 framing the latest quarter in a wider earnings run-rate. The company has seen quarterly revenue move from ¥8.52b in Q1 2025 to ¥10.96b in Q2 2026, while basic EPS over the same period has ranged from ¥49.96 to ¥169.63, giving investors a clear view of how the top and bottom line have tracked through recent reporting periods. With a reported net profit margin of 20.2% over the last twelve months versus 12% a year earlier, the focus now turns to how the durability of these margins compares with forward expectations.

See our full analysis for Osaka Organic Chemical Industry.

Next up, the numbers are set against the widely followed market and community narratives to see which views on Osaka Organic Chemical Industry hold up and which start to look stretched.

Curious how numbers become stories that shape markets? Explore Community Narratives

TSE:4187 Revenue & Expenses Breakdown as at Jul 2026
TSE:4187 Revenue & Expenses Breakdown as at Jul 2026

TTM profit jumps 88.7% on stronger margins

  • On a trailing twelve month basis, Osaka Organic Chemical Industry generated ¥7,841.9 million in net income, with profit up 88.7% over the past year and net margin at 20.2% compared with 12% a year earlier.
  • What stands out for the bullish view is that higher trailing profitability and margins are paired with Q2 2026 revenue of ¥10,961.8 million and Q1 2026 revenue of ¥9,072.9 million. However, part of that 88.7% profit growth reflects a ¥3,200 million one off gain, which means:
    • Supporters who point to stronger margins and earnings power can lean on the 20.2% net margin and ¥7,841.9 million in trailing net income, but need to recognise that the one off item boosted those figures.
    • Skeptics who worry that reported strength is not fully repeatable can point directly to the ¥3,200 million one off amount as a key reason to adjust how they interpret the trailing growth headline.

Forecast earnings decline contrasts with 7.6% revenue growth

  • Analysts in the dataset expect Osaka Organic Chemical Industry’s revenue to grow about 7.6% per year, while earnings are forecast to decline around 8.5% per year over the next three years.
  • Critics with a bearish tilt focus on this split between top line and bottom line, arguing that the projected decline in earnings despite mid single digit revenue growth raises questions about profit durability, because:
    • The current 20.2% trailing net margin and ¥385.42 in trailing EPS sit against expectations for earnings to fall over time, so bears see limited support for extrapolating recent profitability into the future.
    • The presence of the ¥3,200 million one off gain in the last twelve months adds to that argument, as it makes the gap between past 88.7% earnings growth and the forecast earnings decline even more pronounced.

P/E discount vs peers but DCF below ¥5,100 share price

  • Osaka Organic Chemical Industry trades on a trailing P/E of 13.2x, below the peer average of 15.4x and the Japan chemicals industry at 13.6x. A DCF fair value of ¥2,086.15 sits well below the current ¥5,100 share price, and analysts’ price target of ¥6,422.50 implies about 25.9% upside.
  • What is interesting for a balanced view is how these valuation signals pull in different directions, as:
    • The P/E discount and analysts’ ¥6,422.50 target relative to the ¥5,100 share price provide numerical backing for investors who see room for upside, especially when combined with the 7.6% revenue growth forecast.
    • The DCF fair value of ¥2,086.15, which is far below the current share price, supports more cautious investors who focus on cash flow based valuation and are wary of the one off gain and the forecast 8.5% annual earnings decline.

For a deeper read on how Osaka Organic Chemical Industry's valuation, growth outlook, and risks fit together, and to see different investor narratives in one place, it is worth checking out the broader community discussion Curious how numbers become stories that shape markets? Explore Community Narratives.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Osaka Organic Chemical Industry's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If the mix of earnings headlines and one off gains around Osaka Organic Chemical Industry feels conflicting, now is a good time to review the figures in detail and stress test your own thesis using the 4 key rewards and 3 important warning signs.

See What Else Is Out There

Osaka Organic Chemical Industry faces a tension between a DCF value well below the ¥5,100 share price, one-off boosted earnings, and forecasts for earnings to decline.

If that mix of valuation signals and profit uncertainty feels uncomfortable, now may be a good time to review stocks in the 19 high quality undervalued stocks that better align with your expectations.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.